Key Takeaways: Scalable Data Strategies for Scientific AI-enabled Breakthroughs

Get the essentials from an expert discussion on AI featuring AWS and TetraScience. 

Artificial intelligence (AI) stands on the brink of revolutionizing the biopharmaceutical industry. It promises to slash time to market, lower costs, mitigate risks, and create novel therapies. However, the main barrier to realizing these benefits is not the development of AI models but rather the quality and accessibility of the scientific data that feeds them.

The recent webinar “Scalable data strategies for scientific AI-enabled breakthroughs” featured insights from industry experts Naveen Kondapalli, Senior Vice President of Product and Engineering at TetraScience, and Himanshu Jain, Healthcare and Life Sciences Strategy Leader at AWS. They delved into the data challenges underlying scientific AI and discussed strategies to overcome them.

In this recap, we summarize four key takeaways from the conversation that will jumpstart your AI journey.

TetraScience + AWS International TA 112223

Your privacy is a top concern for us at Knowledge Hub Media. We’ll only use your personal information to provide you with the content, products and/or services you’ve requested from us. By clicking the "Submit" button below, you are confirming that you have carefully read Knowledge Hub Media’s Terms of Use agreement, and Privacy Policy, and agree to be legally bound by all such terms.